TELOMIR-1

N/A

Report date: 2025/06/12 11:47:05
NME

Base Information

Drug NameTELOMIR-1
Drug Alias NameTELOMIR-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTelomerase activatorsIron chelating agents
TargetsTelomerase
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTelomir Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A